our mission

To develop and commercialize self-administered parenteral medicines that optimize clinical benefits with enhanced cost effective health outcomes

news / press releases

  • 26 January 2015

    Antares Pharma Provides Regulatory Update on Sumatriptan Injection USP
  • 13 January 2015

    Antares Pharma Announces Update to Quick Shot Testosterone Program
  • 8 January 2015

    Antares Pharma to Present at the 33rd Annual JP Morgan Healthcare Conference
  • 3 December 2014

    Antares Pharma to Present at the 25th Annual Oppenheimer Healthcare Conference
  • 25 November 2014

    Antares Pharma to Present at the 26th Annual Piper Jaffray Healthcare Conference
  • 18 November 2014

    Antares Pharma Appoints James E. Fickenscher, Senior Vice President, Chief Financial Officer

latest products & technology


Otrexup (methotrexate) injection for subcutaneous use only.

Learn More >>